Join to view full profile
260-08 Union tpkGlen Oaks, NY 11004
Phone+1 718-347-0411
Fax+1 718-347-0455
Dr. Mehrishi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr Anshu Mehrishi is board certified in Internal medicine,Hematology,Medical Oncology and Hospice & Palliative care medicine. 25 years of experience in treating various malignancies and hematologic disorders.Also provide palliative care from the beginning of cancer diagnosis. All under one roof in an outpatient clinic with homely environment, much liked by patients.
Education & Training
Nassau University Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2003- Nassau University Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2002
- Nassau University Medical CenterResidency, Internal Medicine, 1997 - 2000
Sawai Man Singh Medical CollegeClass of 1992
Certifications & Licensure
NY State Medical License 2009 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Medgen EHR, Comtron Corp., 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification MEDGEN EHR, Comtron Corp., 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification Medgen EHR, Comtron Corp., 2013, 2015, 2017
Publications & Presentations
PubMed
- 13 citationsPrimary squamous cell carcinoma of the liver.Seeta Naik, Waris Waris, Linda Carmosino, Anshu Mehrishi, Muhammad Wasif Saif
Journal of Gastrointestinal and Liver Diseases. 2009-12-01 - 6 citationsSevere cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.Waris Waris, Seeta Naik, Imran Idrees, Hesham Taha, Linda Camosino
Cutaneous and Ocular Toxicology. 2009-03-01 - 6 citationsPrimary Pulmonary PlasmacytomaGulvahid Shaikh, Rahul Sehgal, Anshu Mehrishi, Ashok Karnik
Journal of Clinical Oncology. 2008-06-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
